Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
8 studies found for:    "spastic paraplegia type 11" OR "Spastic Paraplegia, Hereditary" OR "Spastic Paraplegia"
Show Display Options
RSS Create an RSS feed from your search for:
"spastic paraplegia type 11" OR "Spastic Paraplegia, Hereditary" OR "Spastic Paraplegia"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis
Conditions: Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Amyotrophic Lateral Sclerosis
Intervention:
2 Active, not recruiting Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
Condition: Spastic Paraplegia, Hereditary
Interventions: Drug: Xenbilox;   Dietary Supplement: Resveratrol;   Drug: Tahor
3 Recruiting Genetic and Physical Study of Childhood Nerve and Muscle Disorders
Conditions: Muscular Dystrophies;   Muscle Myopathies;   Hereditary Spastic Paraplegias;   Inherited Neuropathies;   Inherited Neuromuscular Conditions
Intervention:
4 Not yet recruiting Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
Intervention:
5 Unknown  SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic Paraplegias
Conditions: Cerebellar Ataxias;   Spastic Paraplegias
Intervention:
6 Unknown  Natural History, Genetic Bases and Phenotype-genotype Correlations in Autosomal Dominant Spinocerebellar Degenerations
Conditions: Spinocerebellar Ataxias;   Spastic Paraplegias
Intervention:
7 Recruiting Treatment With Xeomin Versus Botox in Children With Spastic Equine and Equinovarus Foot Deformation in Pediatric Cerebral Palsy
Conditions: Cerebral Palsy;   Spastic Paraplegia and Hemiparesis;   Equine and Equinovarus Foot Deformation
Interventions: Drug: Xeomin;   Drug: Botox®
8 Completed Assessment of Patients With Multiple Sclerosis (MS)
Conditions: Herpesviridae Infection;   HTLV-I Infection;   Multiple Sclerosis;   Tropical Spastic Paraparesis;   Vasculitis
Intervention:

Indicates status has not been verified in more than two years